Authors: Ben Aïssa A; Service d'oncologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland.

Source: Praxis [Praxis (Bern 1994)] 2023; Vol. 112 (3), pp. 135-142.

Publication Type: Journal Article

Journal Info: Publisher: Hans Huber Country of Publication: Switzerland NLM ID: 101468093 Publication Model: Print Cited Medium: Print ISSN: 1661-8157 (Print) Linking ISSN: 16618157 NLM ISO Abbreviation: Praxis (Bern 1994) Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Melanoma*/therapy , Skin Neoplasms*/therapy, Humans ; Skin

Authors: Ledford H

Source: Nature [Nature] 2023 Jan; Vol. 613 (7945), pp. 626-628.

Publication Type: News

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

MeSH Terms: Neoplasms*/immunology , Neoplasms*/therapy , T-Lymphocytes*/immunology , Immunotherapy, Adoptive*/methods , Immunotherapy, Adoptive*/standards , Immunotherapy, Adoptive*/trends, Humans

Authors: Lazaroff J; Department of Medicine, Section of Dermatology, University of Chicago, The University of Chicago Medicine, 5841 S Maryland Avenue MC 5067, Chicago, IL 60637, USA. Electronic address: Jake.Lazaroff@uchospitals.edu., Bolotin D; Department of Medicine, Section of Dermatology, University of Chicago, The University of Chicago Medicine, 5841 S Maryland Avenue MC 5067, Chicago, IL 60637, USA.

Source: Dermatologic clinics [Dermatol Clin] 2023 Jan; Vol. 41 (1), pp. 65-77. Date of Electronic Publication: 2022 Oct 28.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Health Sciences Division Country of Publication: United States NLM ID: 8300886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-0520 (Electronic) Linking ISSN: 07338635 NLM ISO Abbreviation: Dermatol Clin Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Melanoma*/drug therapy , Melanoma*/pathology, Humans ; Molecular Targeted Therapy ; Prognosis

Authors: Gustafson MP; Immuno-Gene Therapy Committee, International Society for Cell and Gene Therapy; Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Phoenix, Arizona, USA., Ligon JA; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida, USA., Bersenev A; Immuno-Gene Therapy Committee, International Society for Cell and Gene Therapy; Department of Laboratory Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, USA., McCann CD; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA; Department of Pediatrics, The George Washington University, Washington, DC, USA., Shah NN; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Hanley PJ; Immuno-Gene Therapy Committee, International Society for Cell and Gene Therapy; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA; Department of Pediatrics, The George Washington University, Washington, DC, USA. Electronic address: phanley@childrensnational.org.

Source: Cytotherapy [Cytotherapy] 2023 Jan; Vol. 25 (1), pp. 20-32. Date of Electronic Publication: 2022 Oct 22.

Publication Type: Review; Journal Article; Research Support, N.I.H., Intramural

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Neoplasms*/genetics , Neoplasms*/therapy, Humans ; Genetic Therapy ; Gene Editing

Authors: Guo B; Department of Experimental Statistics, Louisiana State University, Baton Rouge, Louisiana, USA., Zang Y; Department of Biostatistics and Data Science, School of Medicine, Indiana University, Indianapolis, Indiana, USA.; Center for Computational Biology and Bioinformatics, Indiana University, Indianapolis, Indiana, USA., Lin LH; Department of Experimental Statistics, Louisiana State University, Baton Rouge, Louisiana, USA., Zhang R; Department of Physics and Astronomy, Louisiana State University, Baton Rouge, Louisiana, USA.; Department of Radiation Oncology, Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, USA.

Source: Pharmaceutical statistics [Pharm Stat] 2023 Jan; Vol. 22 (1), pp. 143-161. Date of Electronic Publication: 2022 Sep 26.

Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 101201192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-1612 (Electronic) Linking ISSN: 15391604 NLM ISO Abbreviation: Pharm Stat Subsets: MEDLINE

MeSH Terms: Algorithms* , Immunotherapy*, Humans ; Bayes Theorem ; Computer Simulation ; Biomarkers ; Research Design ; Dose-Response Relationship, Drug

Authors: Xiao BY; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China., Zhang X; Department of Colorectal Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Guangzhou, China., Cao TY; Department of Medical Oncology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Li DD; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China., Jiang W; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China., Kong LH; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China., Tang JH; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China., Han K; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China., Zhang CZ; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China., Mei WJ; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China., Xiao J; Department of Medical Oncology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Pan ZZ; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China., Li YF; Department of Colorectal Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Guangzhou, China., Zhang XS; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China., Ding PR; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.

Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2023 Jan; Vol. 21 (1), pp. 60-66.e5.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

MeSH Terms: Colonic Neoplasms*/drug therapy , Colonic Neoplasms*/genetics , Colonic Neoplasms*/therapy , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/therapy , Immunotherapy* , Neoadjuvant Therapy*/methods, Adolescent ; Adult ; Aged ; Humans ; Middle Aged ; Young Adult ; DNA Mismatch Repair ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Microsatellite Instability

SCR Disease Name: Turcot syndrome

Authors: Hasmat S; Department of Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health Sciences, University of Sydney, Camperdown, New South Wales, Australia., Howle JR; Department of Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health Sciences, University of Sydney, Camperdown, New South Wales, Australia., Carlino MS; Sydney Medical School, Faculty of Medicine and Health Sciences, University of Sydney, Camperdown, New South Wales, Australia.; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Westmead, New South Wales, Australia.; Melanoma Institute Australia, Sydney, New South Wales, Australia., Sundaresan P; Sydney Medical School, Faculty of Medicine and Health Sciences, University of Sydney, Camperdown, New South Wales, Australia.; Department of Radiation Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia., Veness MJ; Sydney Medical School, Faculty of Medicine and Health Sciences, University of Sydney, Camperdown, New South Wales, Australia.; Department of Radiation Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia.

Source: ANZ journal of surgery [ANZ J Surg] 2023 Jan; Vol. 93 (1-2), pp. 235-241. Date of Electronic Publication: 2022 Dec 25.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Publishing Asia Country of Publication: Australia NLM ID: 101086634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1445-2197 (Electronic) Linking ISSN: 14451433 NLM ISO Abbreviation: ANZ J Surg Subsets: MEDLINE

MeSH Terms: Carcinoma, Squamous Cell*/therapy , Immunotherapy* , Skin Neoplasms*/therapy, Humans ; Neoplasm Recurrence, Local ; Treatment Outcome

Authors: Desai A; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Subbiah V; Department of Investigational Cancer Therapeutics (phase 1 clinical trials program), Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; MD Anderson Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Source: Cancer [Cancer] 2023 Jan 01; Vol. 129 (1), pp. 11-14. Date of Electronic Publication: 2022 Oct 30.

Publication Type: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Neoplasms*/therapy, Humans

Authors: Li H; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China., Fu Q; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China., Muluh TA; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Key Laboratory for Biorheological Science and Technology of Ministry of Education, Bioengineering College of Chongqing University, Chongqing, China., Shinge SAU; Department of Cardiovascular Surgery, The Affiliated Hospital of Southwest Medical University, China., Fu S; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China., Wu J; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Department of Cardiovascular Surgery, The Affiliated Hospital of Southwest Medical University, China.; Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

Source: Recent patents on anti-cancer drug discovery [Recent Pat Anticancer Drug Discov] 2023; Vol. 18 (1), pp. 53-65.

Publication Type: Review; Journal Article

Journal Info: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101266081 Publication Model: Print Cited Medium: Internet ISSN: 2212-3970 (Electronic) Linking ISSN: 15748928 NLM ISO Abbreviation: Recent Pat Anticancer Drug Discov Subsets: MEDLINE

MeSH Terms: Neoplasms*/drug therapy , Nanotechnology* , Immunotherapy*, Humans

Transliterated Title: Développement des CAR-T cells dans les tumeurs solides.

Authors: El Ghazzi N; CHU Gabriel Montpied, service d'oncologie médicale, Clermont-Ferrand, France; Université Clermont Auvergne, Clermont-Ferrand, France., Italiano A; Institut Bergonié, unité de phases précoces, Bordeaux, France; Université de Bordeaux, Bordeaux, France., Bay JO; CHU Gabriel Montpied, service d'oncologie médicale, Clermont-Ferrand, France; Université Clermont Auvergne, Clermont-Ferrand, France., Dougé A; CHU Gabriel Montpied, service d'oncologie médicale, Clermont-Ferrand, France; Université Clermont Auvergne, Clermont-Ferrand, France. Electronic address: adouge@chu-clermontferrand.fr.

Source: Bulletin du cancer [Bull Cancer] 2023 Jan; Vol. 110 (1), pp. 32-41. Date of Electronic Publication: 2022 Dec 19.

Publication Type: English Abstract; Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: France NLM ID: 0072416 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6917 (Electronic) Linking ISSN: 00074551 NLM ISO Abbreviation: Bull Cancer Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive*/methods , Neoplasms*/therapy, Humans ; Antigens, Neoplasm ; T-Lymphocytes ; Neovascularization, Pathologic ; Tumor Microenvironment

Authors: Zhang Y; Department of Oncology, The People's Hospital of Luzhou, 646000 Luzhou, Sichuan, P.R. China., Li Y; Department of Oncology, The People's Hospital of Luzhou, 646000 Luzhou, Sichuan, P.R. China., Fu Q; Department of Oncology, The People's Hospital of Luzhou, 646000 Luzhou, Sichuan, P.R. China., Han Z; Department of Oncology, The People's Hospital of Luzhou, 646000 Luzhou, Sichuan, P.R. China., Wang D; Department of Oncology, The People's Hospital of Luzhou, 646000 Luzhou, Sichuan, P.R. China., Umar Shinge SA; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Sichuan, P.R. China., Muluh TA; Department of Cardiovascular Surgery, The Affiliated Hospital of Southwest Medical University, Sichuan, P.R. China.; School of Medicine, Health Science Center, Shenzhen University, Shenzhen 518060, P.R. China., Lu X; Department of Oncology, The People's Hospital of Luzhou, 646000 Luzhou, Sichuan, P.R. China.

Source: Current cancer drug targets [Curr Cancer Drug Targets] 2023; Vol. 23 (4), pp. 251-264.

Publication Type: Review; Journal Article

Journal Info: Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101094211 Publication Model: Print Cited Medium: Internet ISSN: 1873-5576 (Electronic) Linking ISSN: 15680096 NLM ISO Abbreviation: Curr Cancer Drug Targets Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Neoplasms*/drug therapy, Humans ; Combined Modality Therapy ; Cytotoxins

Authors: Tan WQ; Department of Surgery, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, China.; Department of Surgery, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, China., Yuan L; Department of Surgery, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, China.; Department of Surgery, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, China., Cao X; Department of Surgery, Children's Hospital of Soochow University, Soochow University, Suzhou, Jiangsu, China.; Department of Surgery, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, China., Wu XY; Department of Surgery, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, China., Xing YQ; Department of Surgery, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, China., Ye M; Department of Surgery, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, China.

Source: Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2023; Vol. 36 (1), pp. 53-61.

Publication Type: Journal Article

Journal Info: Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101256509 Publication Model: Print Cited Medium: Internet ISSN: 1875-8592 (Electronic) Linking ISSN: 15740153 NLM ISO Abbreviation: Cancer Biomark Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Neuroblastoma*/genetics , Neuroblastoma*/therapy , RNA, Long Noncoding*/genetics , Dendritic Cells* , Cytokine-Induced Killer Cells*, Animals ; Humans ; Mice ; Cell Line, Tumor ; Cytotoxicity, Immunologic ; Interleukin-12 ; Interleukin-2 ; MicroRNAs

Authors: Heuser C; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy (LIT), 93053 Regensburg, Germany. Electronic address: christoph.heuser@ukr.de., Renner K; Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany; Department of Otorhinolaryngology, University Hospital Regensburg, 93053 Regensburg, Germany., Kreutz M; Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany; Clinical Cooperation Group Immunometabolomics, Leibniz Institute for Immunotherapy (LIT), 93053 Regensburg, Germany; Center for Immunomedicine in Transplantation and Oncology (CITO), University Hospital Regensburg, 93053 Regensburg, Germany., Gattinoni L; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy (LIT), 93053 Regensburg, Germany; Center for Immunomedicine in Transplantation and Oncology (CITO), University Hospital Regensburg, 93053 Regensburg, Germany; University of Regensburg, 93053 Regensburg, Germany. Electronic address: luca.gattinoni@ukr.de.

Source: Seminars in cancer biology [Semin Cancer Biol] 2023 Jan; Vol. 88, pp. 32-45. Date of Electronic Publication: 2022 Dec 07.

Publication Type: Journal Article; Review

Journal Info: Publisher: Academic Press Country of Publication: England NLM ID: 9010218 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-3650 (Electronic) Linking ISSN: 1044579X NLM ISO Abbreviation: Semin Cancer Biol Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Neoplasms*/metabolism, Humans ; Lactates ; Tumor Microenvironment

Authors: Zhang Q; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China., Zhang W; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China., Lin T; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China., Lu W; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China., He X; Department of Urology, Drum Tower Hospital Clinical College of Nanjing Medical University, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China., Ding Y; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China., Chen W; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China., Diao W; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China., Ding M; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China., Shen P; State Key Laboratory of Pharmaceutical Biotechnology, Department of Urology, School of Life Science, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing University, Nanjing, 210023, Jiangsu, China. ppshen@nju.edu.cn., Guo H; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China. dr.ghq@nju.edu.cn.

Source: BMC cancer [BMC Cancer] 2022 Jun 20; Vol. 22 (1), pp. 677. Date of Electronic Publication: 2022 Jun 20.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Ding Y; Medical School of Southeast University, Nanjing, 210009, China., Wang L; Medical School of Southeast University, Nanjing, 210009, China., Li H; Department of Tuberculosis, the Second Affiliated Hospital of Southeast University (the Second Hospital of Nanjing), Nanjing, 210009, China., Miao F; Medical School of Southeast University, Nanjing, 210009, China., Zhang Z; Department of Neurosurgery, Nanjing Jinling Hospital, Nanjing University, Nanjing, 210002, China., Hu C; Department of Tuberculosis, the Second Affiliated Hospital of Southeast University (the Second Hospital of Nanjing), Nanjing, 210009, China., Yu W; Medical School of Southeast University, Nanjing, 210009, China. wpylg@hotmail.com., Tang Q; Medical School of Southeast University, Nanjing, 210009, China. panyixi-tqs@163.com., Shao G; Department of Interventional Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China. shaogl@zjcc.org.cn.

Source: Journal of nanobiotechnology [J Nanobiotechnology] 2022 May 06; Vol. 20 (1), pp. 214. Date of Electronic Publication: 2022 May 06.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE

Authors: An L; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Lin Y; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Deng B; Cytology Laboratory, Beijing Boren Hospital, Beijing, China., Yin Z; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Zhao D; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Ling Z; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Wu T; Department of Hematopoietic Cell Transplantation, Beijing Boren Hospital, Beijing, China., Zhao Y; Department of Hematopoietic Cell Transplantation, Beijing Boren Hospital, Beijing, China., Chang AH; Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China., Tong C; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Liu S; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China. liusy@borenhospital.com.

Source: BMC cancer [BMC Cancer] 2022 Apr 12; Vol. 22 (1), pp. 393. Date of Electronic Publication: 2022 Apr 12.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Dianat-Moghadam H; Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Dianat.h@med.mui.ac.ir., Mahari A; Department of Biomedical Engineering, University of Arkansas, Fayetteville, AR, USA., Salahlou R; Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Khalili M; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran., Azizi M; Department of Tissue Engineering and Biomaterials, School of Advanced Medical Sciences and Technologies, Hamadan University of Medical Sciences, Hamadan, Iran., Sadeghzadeh H; Department of Tissue Engineering, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

Source: Stem cell research & therapy [Stem Cell Res Ther] 2022 Apr 08; Vol. 13 (1), pp. 150. Date of Electronic Publication: 2022 Apr 08.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101527581 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-6512 (Electronic) Linking ISSN: 17576512 NLM ISO Abbreviation: Stem Cell Res Ther Subsets: MEDLINE

Authors: Lei K; Institute of Materials Science and Engineering, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland., Kurum A; Institute of Materials Science and Engineering, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland., Kaynak M; Institute of Mechanical Engineering, EPFL, Lausanne, Switzerland., Bonati L; Institute of Bioengineering, EPFL, Lausanne, Switzerland., Han Y; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Cencen V; Institute of Bioengineering, EPFL, Lausanne, Switzerland., Gao M; Institute of Bioengineering, EPFL, Lausanne, Switzerland., Xie YQ; Institute of Bioengineering, EPFL, Lausanne, Switzerland., Guo Y; Institute of Bioengineering, EPFL, Lausanne, Switzerland., Hannebelle MTM; Institute of Bioengineering, EPFL, Lausanne, Switzerland., Wu Y; Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China., Zhou G; Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China., Guo M; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Fantner GE; Institute of Bioengineering, EPFL, Lausanne, Switzerland., Sakar MS; Institute of Mechanical Engineering, EPFL, Lausanne, Switzerland.; Institute of Bioengineering, EPFL, Lausanne, Switzerland., Tang L; Institute of Materials Science and Engineering, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland. li.tang@epfl.ch.; Institute of Bioengineering, EPFL, Lausanne, Switzerland. li.tang@epfl.ch.

Source: Nature biomedical engineering [Nat Biomed Eng] 2021 Dec; Vol. 5 (12), pp. 1411-1425. Date of Electronic Publication: 2021 Dec 06.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2157-846X (Electronic) Linking ISSN: 2157846X NLM ISO Abbreviation: Nat Biomed Eng Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Neoplasms*/therapy, Animals ; Immunotherapy ; Interferon-gamma ; Mice ; T-Lymphocytes

Authors: DePeaux K; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA., Delgoffe GM; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. gdelgoffe@pitt.edu.; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA. gdelgoffe@pitt.edu.

Source: Nature reviews. Immunology [Nat Rev Immunol] 2021 Dec; Vol. 21 (12), pp. 785-797. Date of Electronic Publication: 2021 Apr 29.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1741 (Electronic) Linking ISSN: 14741733 NLM ISO Abbreviation: Nat Rev Immunol Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Tumor Microenvironment*, Neoplasms/*metabolism , Neoplasms/*therapy, Animals ; Glucose/metabolism ; Humans ; Hydrogen-Ion Concentration ; Hypoxia/metabolism ; Immunotherapy, Adoptive ; Oncolytic Viruses

Authors: Fulmali A; University Hospital Southampton NHS Foundation Trust, Southampton, UK., Kimkool P; Imperial College NHS Healthcare Trust, London, UK.

Source: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2021 Nov; Vol. 51 (11), pp. 1407-1409. Date of Electronic Publication: 2021 Sep 02.

Publication Type: Editorial

Journal Info: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8906443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2222 (Electronic) Linking ISSN: 09547894 NLM ISO Abbreviation: Clin Exp Allergy Subsets: MEDLINE

MeSH Terms: Asthma* , Sublingual Immunotherapy*/adverse effects, Allergens/therapeutic use ; Humans ; Immunotherapy